The study is highly significant for the treatment of low bone mass in patients with β-thalassemia, which is a yet unexplored field of research. Β-Thalassemia is a devastating genetic disease in which severe anemia is associated with high levels of ERFE.
← all excerpts
The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry.
1
—
—